Clovis Oncology, Inc. (CLVS) Stock Soars Amid Continuing Meme Stock Phenomenon
Clovis Oncology, Inc. (CLVS) stock prices were up by 4.77% as of the market closing on June 8th, 2021, bringing the price per share up to USD$5.71 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by a significant 18.21% bringing it up to USD$6.75. Get the hottest stocks […]
Cullinan Oncology, Inc. (CGEM) Stock Surges Following Positive Supplementary CLN-081 Study Information
Cullinan Oncology, Inc. (CGEM) stock prices were up by 18.63% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$35.30 early on in the trading day. CLN-081 Trial Update The oncology company announced supplementary information about Cullinan Pearl’s ongoing Phase 1/2a trial of CLN-081 on June 4th, 2021. […]
CoherusBioSciences, Inc. (CHRS) Stock on the Rise Following Success of JUPITER-02 Pivotal Study
CoherusBioSciences, Inc. (CHRS) stock prices were up by 3.53% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$13.50 early on in the trading day. JUPITER-02 Results The company recently announced the successful results from its pivotal study, JUPITER-02, which was a randomized, double-blind, placebo-controlled Phase 3 clinical […]
Akebia Therapeutics, Inc. (AKBA) Stock On the Rise Following Progression of Vadadastut’s Commercial Development
Akebia Therapeutics, Inc. (AKBA) stock prices were up by a marginal 0.29% as of the market closing on May 28th, 2021, bringing the price per share up to USD$3.51 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by a significant 9.97%, bringing it up to USD$3.86. NDA Submission […]
Berkeley Lights, Inc. (BLI) Stock Undergoes Minor Volatility as Development of Opto Assure Continues
Berkeley Lights, Inc. (BLI) stock prices were down by 3.18% as of the market closing on May 28th, 2021, bringing the price per share down to USD$43.50 at the end of the trading day. Revenue Reports and Growth in Bases The leader in Digital Cell Biology reported having generated USD$18.6 million in total revenue over […]
Liminal BioSciences Inc. (LMNL) Stock on the Rise Following Collaborative Agreements with Kedrion
Liminal BioSciences Inc. (LMNL) stock prices were up 4.49% as of the market close on May 28th, 2021, bringing the price per share up to USD$4.42 at the end of the trading day. Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Divestment of Plasma Centers The […]
Chiasma, Inc. (CHMA) Stock Surged After Disclosure of Q1 2021 Financial Reports
Chiasma, Inc. (CHMA) stock prices were up by a marginal 0.24% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.22 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 4.27%, bringing it up to USD$4.40. Get the hottest stocks to […]
Purple Biotech Ltd. (PPBT) Stock Undergoes Minor Volatility Amid Progression of CM24 Clinical Trial
Purple Biotech Ltd. (PPBT) stock prices were up by 2.15% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.76 at the end of the trading day. Subsequent pre-market fluctuations saw the price dip by a marginal 1.05%, bringing it down to USD$4.71. CM24 Trial Commences Patient Dosing […]
Protegenic Therapeutics, Inc. (PTIX) Stock Trending Higher Despite Absence of News
Protegenic Therapeutics, Inc. (PTIX) share price was up by 11.37% as of the market opening on May 25th, 2021, bringing the price per share up to USD$2.35 shortly after the trading day commenced. PTIX Background PTIX is a pre-clinical biopharmaceutical company that endeavors to develop first-in-class neuro-active peptides in treatments for anxiety, treatment-resistant depression, addiction, […]
Hoth Therapeutics, Inc. (HOTH) Stock Poised to Surge Pending Orphan Drug Designation Approval
Hoth Therapeutics, Inc. (HOTH) stock prices were up by 6.43% as of the market closing on May 21st, 2021, bringing the price per share up to USD$1.49 at the end of the trading day. Subsequent pre-market fluctuations saw the price fall by a marginal 2.68%, bringing it down to USD$1.45. HT-KIT HOTH announced early in […]
Onconova Therapeutics, Inc. (ONTX) Stock Skyrockets Following Reverse Stock Split
Onconova Therapeutics, Inc. (ONTX) stock prices were down by a substantial 21.08% as of the market closing on May 20th, 2021, bringing the price per share down to USD$0.73 at the end of the trading day. Subsequent pre-market fluctuations saw the price skyrocket by a monumental 1235.62%, bringing the price per share up to USD$9.69. […]
PolarityTE, Inc. (PTE) Stock Trending Down Shortly After Disclosure of Promising Q1 2021 Financials
PolarityTE, Inc. (PTE) stock prices were down by 6.62% as of the market closing on May 17th, 2021, bringing the price per share down to USD$0.912 at the end of the trading day. Promising Trajectory The company consolidated its prior guidance in the first quarter of the fiscal year 2021 in regard to the submission […]
BioLineRx Ltd. (BLRX) Stock Floats Back Down After Skyrocketing from Success of GENESIS Trial
BioLineRx Ltd. (BLRX) stock prices were down by 3.38% as of the market closing on May 7th, 2021, bringing the price per share down to USD$3.72. Subsequent pre-market fluctuations saw the price fall by another 4.30%, bringing it to USD$3.56. Phase 3 GENESIS Trial The achieving of top-line results by BLRX for their GENESIS Phase […]
Orphazyme A/S (ORPH) Stock Plummeting After Failure of ORAIALS-01 Trial Announced
Orphazyme A/S (ORPH) stock prices plummeted by 27.77% after the market opened on May 7th, 2021, bringing the price per share tumbling down to USD$6.12 after the commencing of the trading day. ORAIALS-01 Ends in Failure The company announced on May 7th, 2021 that the ORAIALS-01 pivotal trial of arimoclomol in amyotrophic lateral sclerosis (ALS) […]
Epizyme, Inc. (EPZM) Stock Experiences Volatility Following Disclosure of Q1 2021 Financial Reports
Epizyme, Inc. (EPZM) stock prices were down by 9.44% as of the market closing on May 6th 2021, bringing the price per share down to USD$6.81 at the end of the trading day. Subsequent current-market fluctuations have seen the stock rally by 20%, bringing it up to USD$8.17. Financial Reports Indicate Strong Growth The first […]
Clovis Oncology, Inc. (CLVS) Stock Trending Up Following Disclosure of Promising Q1 2021 Financial Reports
Clovis Oncology, Inc. (CLVS) stock prices were up a promising 8.89% shortly after the trading day commenced on May 5th, 2021, bringing the price per share up to USD$6.00. Comparative Decrease in Revenue CLVS reported USD$38.1 million in global net product revenues derived from the company’s flagship Rubraca in the first quarter of the fiscal […]
BioLineRX Ltd (BLRX) Stock Skyrockets Following Immense Success of Phase 3 GENESIS Clinical Trial
BioLineRx Ltd. (BLRX) stock prices skyrocketed by 52.98% as of market close on May 3rd 2021, bringing the price per share up to USD$4.88 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock surge another 16.6% to hit USD$5.69. Phase 3 GENESIS trial BLRX announced on May 4th, 2021 the […]